Study of Bexxar <Tositumomab> Combined With External Beam Radiation Therapy

NCT00490490 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped Low Accrual

Conditions

Lymphoma, Non-Hodgkin

Interventions

DRUG: Bexxar (tositumomab)
PROCEDURE: External beam radiotherapy (XRT)
DRUG: Potassium Iodide (KI)

Sponsor

Stanford University

Collaborators

[object Object]